Findings about the cholinergic basal forebrain using immunotoxin to the nerve growth factor receptor.
Wiley
R G
RG
Department of Neurology, Vanderbilt University, Nashville, Tennessee, USA. ronald.g.wiley@vanderbilt.edu
D000544:Alzheimer Disease / Q000503:physiopathology; D000818:Animals; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D002799:Cholinergic Fibers / Q000502:physiology*; D004195:Disease Models, Animal; D000922:Immunotoxins; D009699:N-Glycosyl Hydrolases; D016548:Prosencephalon / Q000502:physiology*; D051381:Rats; D017475:Receptors, Nerve Growth Factor / Q000502:physiology*; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins
C085696:192 IgG-saporin; D000911:Antibodies, Monoclonal; D018678:Cholinergic Agents; D000922:Immunotoxins; D017475:Receptors, Nerve Growth Factor; D054789:Ribosome Inactivating Proteins, Type 1; D009699:N-Glycosyl Hydrolases; D000076985:Saporins